Table 2.
Methods used for advanced haemodynamic monitoring in their hospitals and how often they use it. Data are shown as percentage with absolute numbers
| Frequently | Rarely | Never | Technology | |||||
|---|---|---|---|---|---|---|---|---|
| Not available | ||||||||
| Pulse contour analysis (n = 1,079) | 43% | (459) | 39% | (422) | 7% | (72) | 12% | (126) |
| TTE (n = 1,079) | 35% | (377) | 44% | (480) | 15% | (158) | 6% | (64) |
| CVP monitoring (n = 1,079) | 32% | (347) | 43% | (466) | 22% | (242) | 2% | (24) |
| TOE (n = 1,079) | 25% | (275) | 48% | (515) | 17% | (179) | 10% | (110) |
| Transpulmonary thermodilution (n = 1,079) | 25% | (273) | 49% | (532) | 12% | (129) | 13% | (145) |
| Pulmonary artery catheter (n = 1,079) | 5% | (52) | 37% | (400) | 29% | (310) | 29% | (317) |
| Finger cuff method (n = 1,079) | 2% | (21) | 11% | (120) | 20% | (217) | 67% | (721) |
| Bioreactance / bioimpedance technology (n = 1,079) | 1% | (15) | 7% | (77) | 16% | (173) | 75% | (814) |
| Esophageal Doppler (n = 1,079) | 1% | (11) | 13% | (136) | 27% | (294) | 59% | (638) |
CVP = Central venous pressure; TOE = Transesophageal echocardiography; TTE = Transthoracic echocardiography